Published on
Between 2014 and 2019, I wrote occasional posts on topics related to reproductive health research, scientific integrity, and evidence standards. Although I am not currently actively maintaining this blog, I'm keeping these posts below available for now.

​For more recent writing, see Talks and Commentary or Research and Publications
Published on
UPDATE 9/9/19: The company that manufactures Daysy is now the subject of a legal investigation. More information is available here: http://www.khuranapc.com/daysy-investigation. If you purchased a Daysy, please be sure to read about the investigation and determine if you would like to speak with these lawyers to share your experience. (NOTE: as of 9/20/19 that link is no longer functional. I will share additional updates as they become available.)


In May 2019, 404 days after I submitted a commentary detailing egregious flaws in data collection and analysis of a study purporting to estimate contraceptive effectiveness of the Daysy thermometer -- that study was retracted from the journal Reproductive Health. The retraction note says: “Independent post-publication peer review has confirmed that there are fundamental flaws in the methodology which mean that the conclusions are unreliable due to selection bias and the retrospective self-reporting of whether pregnancies were intentional.”
 
Science reporter Stephanie Lee covered the retraction story in Buzzfeed. Prior writings had investigated Daysy and detailed unethical behaviors by Valley Electronics (Daysy’s manufacturer) – including that the company kicked people out of online forums for asking questions, and used manipulative language in their marketing materials. In a comment on PubPeer, I also detailed unethical behaviors by Valley Electronics.
 
I’m glad to have helped to remove junk science from the literature. Hopefully, fewer people will be made vulnerable to unintended pregnancy via misleading, unsupported claims. While the retraction was very important, it does not fully solve the problem. Elsewhere, I’ve described the concerning asymmetry between the rapid spread of misinformation on social media and the long, slow process of addressing misinformation in the scientific literature, and how this mismatch can ultimately impact public health.
 
So, I have more to say.
Published on
A few years ago, the Department of Population, Family, and Reproductive Health at Johns Hopkins Bloomberg School of Public Health asked me to give an "Amazing Alumni" lecture, as part of their 100th anniversary celebrations. I was beyond honored to be one of six alumni chosen to give a talk! I was asked to reflect on my career trajectory. Since most talks I do focus on research findings - it was a challenge (an intimidating one!) to put together a talk that was more personal. It was even more intimidating to deliver it to a room full of the people who taught me much of what I know about global public health!

I've worked on some controversial issues in sexual and reproductive health, so decided to make 'controversy' the theme. In retrospect, I'm annoyed I didn't sneak this Prince song in to the talk, but...live and learn.

It was a fun opportunity to reflect on some lessons learned so far in my career. The audio recording of my talk is posted here (a few minutes seem to be skipped near the end), and slides can be downloaded below.
Published on
I've admired the FPVoices project by K4Health and FP2020 for so long, and was very honored when they asked to interview me at the International Conference on Family Planning in Rwanda in November 2018.

In an audio interview posted on Soundcloud, we chat about what got me interested in reproductive health, who inspires me, working on controversial issues, doing systematic reviews, and subjects like hormonal contraception and HIV, fertility awareness based methods, multipurpose prevention technologies, reproductive justice, infertility, and more.

To see other #FPVoices, check out their wonderful page: http://fpvoices.tumblr.com/. I feel very grateful to be part of this community!
Published on
What if I told you that a fancy thermometer was "similar in effectiveness" as an IUD at preventing pregnancy, and only required you to take your temperature once a day?
 
Well, if I told you that, I’d be misleading you and putting you at risk of an unintended pregnancy.
 
But, that’s what a company called Valley Electronics AG has been telling consumers, in hopes of selling their $330 device called Daysy.
Picture
Picture
Published on
Over the last several years, I've been collaborating on a project on measuring infertility in low resource settings with an amazing group of friends/colleagues: Dr. Carie CoxDr. Ozge Tuncalp, Dr. Alex McLain, and Dr. Marie ThomaThe journal Human Reproduction recently published our manuscript, called: Estimating infertility prevalence in low- to middle-income countries: an application of a current duration approach to Demographic and Health Survey data.
Picture
Published on
In May 2017, Natural Womanhood and FACTS put out a call for people to sign their petition asking CDC to “update its website to reflect the best data available and to cite the individual effectiveness rate of each unique type of evidence-based fertility awareness based method (FABM)”, asserting that the CDC website currently “misrepresents the actual effectiveness of individual modern FABMs” by reporting a typical failure rate for all FABMs of 24%. They state that data on effectiveness of FABMs on the CDC website is based on “one study with a low quality research design, which explains why its conclusions are so far from what quality studies show us”. They posit “bias” in this estimate as it is based on a retrospective survey, and as it lumps together variants of calendar rhythm plus other FABMs. The assertions in this petition raise multiple concerns (outlined below).
Published on
For many years, scientists have tried to answer several questions about whether various hormonal contraceptive methods (i.e., pills, injectables, implants, hormone-releasing IUDs, patches, and vaginal rings) impact various HIV-related risks. Key questions on this subject include:
  1. Are HIV-negative women who use specific methods of hormonal contraception more likely to acquire HIV?
  2. Are women living with HIV who use specific methods of hormonal contraception more likely to transmit their infection to a male sexual partner?
  3. Are women living with HIV and using specific methods of hormonal contraception likely to experience faster clinical disease progression?
  4. If a woman living with HIV is using antiretroviral therapy (i.e., medications to treat HIV), will using any specific method of hormonal contraception result in drug interactions. In other words, could using both medications at the same time make either medication less effective, or more likely to result in side effects?

The first question is the most controversial, and is a critically important question for women's health - particularly for those living in high HIV prevalence countries, including many in Eastern and Southern Africa. However, for a number of methodological reasons (many of which are detailed in this paper), it is extremely complex to design studies that will provide definitive answers.
Published on
In January 2016, I attended the fourth International Conference on Family Planning. I've been very fortunate to be able to attend all four of these incredible gatherings: in Uganda in 2009, in Senegal in 2011, in Ethiopia in 2013, and in Indonesia in 2016.

At these conferences, I'm always reminded what it feels like to be surrounded by everyday heroes working in reproductive health, and I inevitably come home more inspired and reinvigorated. This year was particularly energized because of the large youth delegation that brought incredible spirit and talents to the conference!
Picture

Hanging out with incredible youth delegates! Left to right: Francis Oko Armah (Ghanaian), Chelsea Polis (American), Patrick Segawa (Ugandan), and Maureen Odour (Kenyan)